|
Small Molecule Activator of MicroRNA-34a
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline 5 August 2021]
We are inviting expressions of interest (EoI) for commercializing “Small molecule activator of microRNA-34a” technology. The innovation is developed by Professor CHEN Yangchao, School of Biomedical Sciences of The Chinese University of...
Inventor(s): Yang Chao Chen
Keywords(s):
Category(s): Therapeutics, Biotechnology
|
|
Engineered globular endolysin, a highly potent antibacterial enzyme for multidrug resistant Gram-negative bacteria
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline 2 July 2021]
We are inviting expressions of interest (EoI) for commercializing “Engineered Globular Endolysin, a Highly Potent Antibacterial Enzyme for Multidrug Resistant Gram-Negative Bacteria” technology. The innovation is developed by Professor XIA...
Inventor(s): Jiang XIA, Shui Yee LEUNG, Xi CHEN, Miao LIU
Keywords(s):
Category(s): Biotechnology, Therapeutics
|
|
A Synbiotic Composition for Immunity
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline: 25 September 2020]
We are inviting expressions of interest (EoI) for commercializing “A Synbiotic Compsotion for Immunity” technology. The innovation is developed by Professor Siew Chien Ng, Professor of the Department of Medicine and Therapeutics of...
Inventor(s): Siew Chien NG, Ka Leung Francis CHAN, Zhilu XU, Wing Yan TANG, Qiaoyi Liang
Keywords(s):
Category(s): Therapeutics
|
|
Methods relating to optimising and personalising microbial therapy
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 9 July 2020]We are inviting expressions of interest (EoI) for commercializing ““Methods relating to optimising and personalising microbial therapy” technology. The innovation is developed by Professor Ng Siew Chien, Professor of Department of Medicine...
Inventor(s): Siew Chien NG, Ka Leung Francis CHAN
Keywords(s):
Category(s): Therapeutics
|
|
Fecal virome and therapeutic efficacy of fecal microbiota transplantation
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 9 July 2020]We are inviting expressions of interest (EoI) for commercializing ““Fecal virome and therapeutic efficacy of fecal microbiota transplantation” technology. The innovation is developed by Professor Ng Siew Chien, Professor of Department...
Inventor(s): Siew Chien NG, Tao ZUO
Keywords(s):
Category(s): Therapeutics
|
|
Fecal fungome and therapeutic efficacy of fecal microbiota transplantation
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 9 July 2020]We are inviting expressions of interest (EoI) for commercializing “Fecal fungome and therapeutic efficacy of fecal microbiota transplantation” technology. The innovation is developed by Professor Ng Siew Chien, Professor of Department of Medicine...
Inventor(s): Siew Chien NG, Tao ZUO, Ka Leung CHAN
Keywords(s):
Category(s): Therapeutics
|
|
Genetic Engineering a TGF-beta Tolerant human NK Cells for treatment of cancer.
[Licensing negotiation in progress][Invitation for Expression of Interest- Deadline: 6 December 2018]We are inviting expressions of interest (EoI) for commercializing “Genetic Engineering a TGF-beta Tolerant human NK Cells for treatment of cancer” technology. The innovation is developed by Professor LAN Hui Yao, Professor of Department...
Inventor(s): Hui Yao LAN
Keywords(s):
Category(s): Therapeutics
|
|
Buffered Propranolol Sublingual Tablet for Treatment of Artrial Fibrilation
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 18 February 2018]We are inviting expressions of interest (EoI) for commercializing “Buffered Propranolol Sublingual Tablet for Treatment of Artrial Fibrilation” technology. The innovation is developed by Professor CHOW Sing Sum Moses, of School of Pharmacy...
Inventor(s): Moses Chow, Yan Feng Wang, Zhong Joan Zuo
Keywords(s):
Category(s): Therapeutics
|
|
Discovery of FDA-approved Drugs as Inhibitors of Fatty Acid Binding Protein 4 Using Molecular Docking Screening
Inventor(s): Chi Cheong David Wan, Yan Wang, Wai Kit Law, Jian Shu Hu, Tsz Ming Denis Ip
Keywords(s): Diabetes, Docking Screening, FABP4 Inhibitors
Category(s): Therapeutics, Biotechnology
|
|
New use of vanoxerine dihydrochloride as an anti-cancer drug for the treatment of liver cancer
Inventor(s): Kwong Sak LEUNG, Xi Nan Shi, Fu Kung Hsiang, Hongjian Li, Man Hon Wong, Chia Mi Marie Lin, Xu Liu, Di Lu
Keywords(s): Anti-cancer Drug, Docking Screening, Fluspirilene, Hepatocellular Carcinoma
Category(s): Biotechnology, Therapeutics
|
